{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:47:24Z","timestamp":1788410844123,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["Lo 274\/10"],"award-info":[{"award-number":["Lo 274\/10"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Community's Seventh Framework Programme","award":["201380"],"award-info":[{"award-number":["201380"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.expneurol.2011.12.014","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T08:21:08Z","timestamp":1324369268000},"page":"70-84","source":"Crossref","is-referenced-by-count":41,"title":["Inter-individual variation in the anticonvulsant effect of phenobarbital in the pilocarpine rat model of temporal lobe epilepsy"],"prefix":"10.1016","volume":"234","author":[{"given":"Marion","family":"Bankstahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens P.","family":"Bankstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.12.014_bb0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eplepsyres.2008.07.007","article-title":"Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus","volume":"82","author":"Bankstahl","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0010","series-title":"Antiepileptic Drugs","first-page":"514","article-title":"Phenobarbital and other barbiturates: clinical efficacy and use in epilepsy","author":"Baulac","year":"2002"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0015","series-title":"Models of Seizures and Epilepsy","first-page":"569","article-title":"Monitoring for seizures in rodents","author":"Bertram","year":"2006"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1528-1167.2007.00980.x","article-title":"Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy","volume":"48","author":"Bethmann","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2008.01.005","article-title":"Antiepileptic drug resistant rats differ from drug responsive rats in GABAA-receptor subunit expression in a model of temporal lobe epilepsy","volume":"31","author":"Bethmann","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0920-1211(03)00114-1","article-title":"Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats","volume":"55","author":"Brandt","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0040","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.0013-9580.2004.16904.x","article-title":"Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus","volume":"45","author":"Brandt","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","article-title":"The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy","volume":"24","author":"Brandt","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0050","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuropharm.2006.05.021","article-title":"Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats","volume":"51","author":"Brandt","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0055","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1523\/JNEUROSCI.0633-10.2010","article-title":"Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy","volume":"30","author":"Brandt","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0060","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/2661","article-title":"Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy","volume":"4","author":"Brooks-Kayal","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneumeth.2008.04.019","article-title":"The pilocarpine model of temporal lobe epilepsy","volume":"172","author":"Curia","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.0013-9580.2005.38704.x","article-title":"A 5-month period of epilepsy impairs spatial memory, decreases anxiety, but spares object recognition in the lithium-pilocarpine model in adult rats","volume":"46","author":"Detour","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0075","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.2000.tb00283.x","article-title":"Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy","volume":"41","author":"Fujikawa","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0080","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1528-1167.2008.01659.x","article-title":"Predictors of pharmacoresistant epilepsy: pharmacoresistant rats differ from pharmacoresponsive rats in behavioral and cognitive abnormalities associated with experimentally induced epilepsy","volume":"49","author":"Gastens","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0920-1211(01)00272-8","article-title":"Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy","volume":"46","author":"Glien","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1528-1157.2002.18101.x","article-title":"Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy","volume":"43","author":"Glien","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.expneurol.2007.03.008","article-title":"Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat","volume":"205","author":"Goffin","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0100","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/j.1528-1167.2007.01263.x","article-title":"Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols","volume":"48","author":"Grabenstatter","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0300","first-page":"367","article-title":"Intractable epilepsy and patterns of psychiatric comorbidity","volume":"97","author":"Hermann","year":"2006","journal-title":"Adv Neurol"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2007.06.003","article-title":"Predictors of pharmacoresistant epilepsy","volume":"75","author":"Hitiris","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(06)70331-3","article-title":"Epilepsy, suicidal behaviour, and depression: do they share common pathogenic mechanisms?","volume":"5","author":"Kanner","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.nbd.2009.12.002","article-title":"Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity","volume":"37","author":"K\u00fccker","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1017\/S1092852900008476","article-title":"Drug treatment of epilepsy: when does it fail and how to optimize its use?","volume":"9","author":"Kwan","year":"2004","journal-title":"CNS Spectr."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1586\/14737175.6.3.397","article-title":"Refractory epilepsy: mechanisms and solutions","volume":"6","author":"Kwan","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0920-1211(94)00070-D","article-title":"Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats","volume":"20","author":"Leite","year":"1995","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0295","series-title":"Intractable epilepsy: Experimental and clinical aspects","first-page":"25","article-title":"Experimental models for intractable epilepsy in nonprimate animal species","author":"L\u00f6scher","year":"1986"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0165","series-title":"Models of Seizures and Epilepsy","first-page":"551","article-title":"Animal models of drug-refractory epilepsy","author":"L\u00f6scher","year":"2006"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1528-1167.2009.02183.x","article-title":"High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy","volume":"51","author":"L\u00f6scher","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-3565(25)20238-5","article-title":"Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats","volume":"258","author":"L\u00f6scher","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0160","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1528-1167.2006.00607.x","article-title":"Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs","volume":"47","author":"L\u00f6scher","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.expneurol.2011.12.014_bb0185","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.yebeh.2003.07.004","article-title":"Epilepsy and cognition","volume":"4","author":"Motamedi","year":"2003","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eplepsyres.2006.10.003","article-title":"Effect of antiepileptic drugs on spontaneous seizures in epileptic rats","volume":"73","author":"Nissinen","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0195","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1008698807530","article-title":"Evaluation of drug treatment outcome in epilepsy: a clinical perspective","volume":"19","author":"Perucca","year":"1997","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0205","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1474-4422(07)70215-6","article-title":"Development of new antiepileptic drugs: challenges, incentives, and recent advances","volume":"6","author":"Perucca","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eplepsyres.2006.12.004","article-title":"Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat","volume":"74","author":"Pitk\u00e4nen","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.expneurol.2010.03.014","article-title":"The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy","volume":"224","author":"Polascheck","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood\u2013brain barrier: evidence from microdialysis experiments in rats","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0230","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuropharm.2010.11.005","article-title":"Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats","volume":"60","author":"Rattka","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(98)00106-5","article-title":"Clinical aspects and biological bases of drug-resistant epilepsies","volume":"34","author":"Regesta","year":"1999","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1535-7511.2008.00272.x","article-title":"Intrinsic severity as a determinant of antiepileptic drug refractoriness","volume":"8","author":"Rogawski","year":"2008","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0240","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0250","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0028-3908(90)90159-O","article-title":"Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats","volume":"29","author":"Rundfeldt","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0255","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0260","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.0013-9580.2003.32803.x","article-title":"Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH\/NINDS\/AES models II workshop","volume":"44","author":"Stables","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0265","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1528-1167.2006.00496.x","article-title":"Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats","volume":"47","author":"van Vliet","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0270","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2003.10.012","article-title":"Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures","volume":"123","author":"Volk","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0275","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nbd.2005.09.006","article-title":"Antiepileptic drug resistant rats differ from drug responsive rats in hippocampal neurodegeneration and GABAA-receptor ligand-binding in a model of temporal lobe epilepsy","volume":"21","author":"Volk","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0920-1211(92)90053-V","article-title":"Lack of changes in seizure susceptibility during the estrous cycle in kindled rats","volume":"13","author":"Wahnschaffe","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2011.12.014_bb0285","series-title":"Models of Seizures and Epilepsy","first-page":"539","article-title":"Therapeutic assays for the identification and characterization of antiepileptic and antiepileptogenic drugs","author":"White","year":"2006"},{"key":"10.1016\/j.expneurol.2011.12.014_bb0290","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1523\/JNEUROSCI.0980-08.2009","article-title":"Development of spontaneous recurrent seizures after kainate-induced status epilepticus","volume":"29","author":"Williams","year":"2009","journal-title":"J. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611004663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611004663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T04:43:40Z","timestamp":1742100220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611004663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0014488611004663"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.12.014","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}